These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 841346

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of calcitonin on metastasis formation by experimental tumors.
    Anghileri LJ, Delbrück HG, Cressent M, Desplan C, Talbot JN, Milhaud G.
    Arch Geschwulstforsch; 1980; 50(2):105-10. PubMed ID: 7436694
    [Abstract] [Full Text] [Related]

  • 23. Pharmacological strategies and micrometastasis: what is known? What must be done?
    Perret GY.
    Minerva Med; 2010 Jun; 101(3):163-78. PubMed ID: 20562804
    [Abstract] [Full Text] [Related]

  • 24. [Radiation therapy and metastasis--biologic and therapeutic aspects].
    Milas L.
    Gan No Rinsho; 1984 Sep; 30(12 Suppl):1605-10. PubMed ID: 6513013
    [No Abstract] [Full Text] [Related]

  • 25. [Mechanism of cancer metastasis and its inhibition--a point of view from clinical aspects].
    Tsubura E, Nishikawa H, Chikata E, Yamashita T.
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1189-95. PubMed ID: 4004286
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinically relevant metastatic breast cancer models to study chemosensitivity.
    Kim LS, Price JE.
    Methods Mol Med; 2005 Jun; 111():285-95. PubMed ID: 15911986
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
    Yang L, Huang Y, Porta R, Yanagisawa K, Gonzalez A, Segi E, Johnson DH, Narumiya S, Carbone DP.
    Cancer Res; 2006 Oct 01; 66(19):9665-72. PubMed ID: 17018624
    [Abstract] [Full Text] [Related]

  • 30. Modern trends in the prevention of cancer recurrence.
    Ketcham AS.
    Aktuelle Probl Chir; 1970 Oct 01; 14():183-211. PubMed ID: 4146418
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Role of plasminogen activators in cancer dissemination. Clinical perspectives].
    Alonso DF, Bal de Kier Joffé E.
    Medicina (B Aires); 1992 Oct 01; 52(3):252-6. PubMed ID: 1342692
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Problems of tumor progression: doubts or hopes at the turn of the Millennium?].
    Tímár J.
    Orv Hetil; 2000 Apr 23; 141(17):891-9. PubMed ID: 10827469
    [Abstract] [Full Text] [Related]

  • 36. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
    Ishii H, Yazawa T, Sato H, Suzuki T, Ikeda M, Hayashi Y, Takanashi Y, Kitamura H.
    Lung Cancer; 2004 Sep 23; 45(3):325-37. PubMed ID: 15301873
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes.
    Nicolson GL.
    Curr Opin Oncol; 1991 Feb 23; 3(1):75-92. PubMed ID: 2043698
    [Abstract] [Full Text] [Related]

  • 40. Invasion and metastasis.
    Carr I, Orr FW.
    Can Med Assoc J; 1983 May 15; 128(10):1164-7. PubMed ID: 6340812
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.